Catalyze is pleased to invite you to an interactive workshop focused on helping innovative companies navigate both the European and Danish funding landscape and assess their readiness for programs such as Eureka Eurostars and all the EIC funding programmes on 29 September 2026.
During this session, our experts will guide you through the requirements, opportunities, and best practices for successfully applying to these programs. You’ll gain practical insights on how to assess your readiness to apply, what elements to prepare, and how to maximize your chances of success.
📍BII, Fluorine & Oxygen rooms – 29 September 2026
09:00 – 09:10 Welcome & Introduction
09:10 – 09:25 The European & Danish Funding Landscape
09:25 – 10:00 Eurostars & EUopStart Deep Dive
10:00 – 10:25 Grand Solutions
10:25 – 10:40 Coffee Break & Networking
10:40 – 11:15 EIC Funding Opportunities
11:15 – 11:45 Funding Readiness Workshop
11:45 – 11:55 How Catalyze Supports Successful Applicants
11:55 – 12:00 Wrap-up & Introduction to Afternoon 1-on-1 Sessions
Peter Ruizendaal MSc, is Senior Managing Consultant in Catalyze’s Life Sciences & Health department. With a background in Biomedical Sciences, he specializes in funding and innovation strategies and has extensive experience supporting organizations in securing funding through programmes such as Horizon Europe, EIC, Eurostars, NIH, and national funding schemes.
Daan van den Burg MSc, is Business Developer in Catalyze’s Life Sciences & Health department. With a background in Biomedical Sciences and a specialization in Molecular Neuroscience, he focuses on the Danish funding landscape and supports Nordic innovators in identifying and securing funding opportunities through programmes such as Horizon Europe, EIC, Eurostars, and Danish national grants.
After the workshop, you can talk with the speakers and have a one-on-one meeting during the office hours, to assess what programme would be suitable for your project (30 minutes per company, online or on-site). All on-site meetings will take place at BII.